Chloral betaine

Chloral betaine (USAN, BAN) (brand names Beta-Chlor, Somilan), also known as cloral betaine (INN), is a sedative-hypnotic drug.[1][2][3][4] It was introduced by Mead Johnson in the United States in 1963.[5] It is a betaine complex with chloral hydrate, which acts as an extended-acting formulation of chloral hydrate which is then metabolized into trichloroethanol, which is responsible for most or all of its effects.[3][4][6]

Chloral betaine
Clinical data
Routes of
administration		Oral
ATC code
  • None
Legal status
Legal status
  • US: Schedule IV
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.017.021
Chemical and physical data
FormulaC7H14Cl3NO4
Molar mass281.541 g/mol g·mol−1
3D model (JSmol)

See also

References
  1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 1231–. ISBN 978-1-4757-2085-3.
  2. I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 72–. ISBN 978-94-011-4439-1.
  3. Ellen L. Bassuk; Stephen C. Schoonover; Alan J. Gelenberg (6 December 2012). The Practitioner's Guide to Psychoactive Drugs. Springer Science & Business Media. pp. 208–. ISBN 978-1-4615-8049-2.
  4. W. Lowry (6 December 2012). Forensic Toxicology: Controlled Substances and Dangerous Drugs. Springer Science & Business Media. pp. 157–. ISBN 978-1-4684-3444-6.
  5. William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 944–. ISBN 978-0-8155-1856-3.
  6. George Morrison Maxwell (6 December 2012). Principles of Paediatric Pharmacology. Springer Science & Business Media. pp. 124–. ISBN 978-1-4684-7544-9.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.